These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Effect of hemodialysis on levels of parathormone in blood of patients with chronic kidney failure]. Starzyk J; Kowalski D Wiad Lek; 1993 Apr; 46(7-8):283-5. PubMed ID: 8249416 [TBL] [Abstract][Full Text] [Related]
4. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Nasri H; Baradaran A; Naderi AS Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479 [TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
6. [Parathyroid hormone and 25-hydroxycholecalciferol concentrations in the serum of patients with kidney transplantations and their radiological correlation]. Kokot F; Zazgornik J; Pietrek J; Schmidt P; Fürst K; Czembirek H; Kopsa H Z Gesamte Inn Med; 1978 Aug; 33(15):516-20. PubMed ID: 358634 [TBL] [Abstract][Full Text] [Related]
7. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Nasri H; Baradaran A J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608 [TBL] [Abstract][Full Text] [Related]
8. Glycaemic control and serum intact parathyroid hormone levels in diabetic patients on haemodialysis therapy. Murakami R; Murakami S; Tsushima R; Ueda C; Mikami K; Ebina T; Kumasaka R; Nakamura N; Okumura K Nephrol Dial Transplant; 2008 Jan; 23(1):315-20. PubMed ID: 17956892 [TBL] [Abstract][Full Text] [Related]
9. Calcitropic hormonal status in north Indian patients with end-stage renal disease. Singh AK; Avula S; Kher V; Rao DS; Mithal A Natl Med J India; 1999; 12(5):202-7. PubMed ID: 10612998 [TBL] [Abstract][Full Text] [Related]
10. RenaGel efficacy in severe secondary hyperparathyroidism. Castro R; Herman A; Ferreira C; Travassos F; Nunes-Azevedo J; Oliveira M Nefrologia; 2002; 22(5):448-55. PubMed ID: 12497746 [TBL] [Abstract][Full Text] [Related]
11. Mineral metabolism and haemoglobin concentration among haemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kimata N; Akiba T; Pisoni RL; Albert JM; Satayathum S; Cruz JM; Akizawa T; Andreucci VE; Young EW; Port FK Nephrol Dial Transplant; 2005 May; 20(5):927-35. PubMed ID: 15728270 [TBL] [Abstract][Full Text] [Related]
12. [Diurnal changes in the levels of immunoreactive parathyroid hormone and calcitonin in patients with chronic renal insufficiency]. Ivić MA; Bogićević M; Djordjević V; Mitić M; Stefanović V Srp Arh Celok Lek; 1992; 120(5-6):141-5. PubMed ID: 1465667 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of renal osteopathy with 5,6-trans-25-hydroxycholecalciferol (author's transl)]. Kraft D; Schaefer K; Grigoleit HG; Offermann G; von Herrath D; Delling G Dtsch Med Wochenschr; 1979 Nov; 104(48):1706-10. PubMed ID: 520165 [TBL] [Abstract][Full Text] [Related]
14. Are PTH serum levels predictive of coronary calcifications in haemodialysis patients? Coen G; Manni M; Mantella D; Pierantozzi A; Balducci A; Condò S; DiGiulio S; Yancovic L; Lippi B; Manca S; Morosetti M; Pellegrino L; Simonetti G; Gallucci MT; Splendiani G Nephrol Dial Transplant; 2007 Nov; 22(11):3262-7. PubMed ID: 17597083 [TBL] [Abstract][Full Text] [Related]
15. [Serum osteocalcin in children with chronic renal insufficiency]. Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853 [TBL] [Abstract][Full Text] [Related]